Vivani Medical Secures $4.5M Capital Raise, Chairman Invests at Premium
VANI sits 52% above its 52-week low of $0.905.
Summary
Vivani Medical announced a $4.5 million capital raise through a registered direct offering and a concurrent private placement, with Chairman Gregg Williams investing $2.0 million at a price above the current market.
Key Events · Financing and Capital Events · VANI
-
Capital Raise Details
The company raised approximately $4.5 million in gross proceeds through a registered direct offering of 1,689,200 shares ($2.5 million) and a concurrent private placement of 1,351,351 shares ($2.0 million).
-
Premium Pricing
Shares in both the registered direct offering and the private placement were priced at $1.48 per share, which is above the current stock price of $1.38.
-
Chairman's Significant Investment
Gregg Williams, Chairman of the Board, invested $2.0 million in the private placement, demonstrating strong insider confidence. This follows his recent significant share purchase on January 20, 2026.
-
Use of Proceeds
The net proceeds are intended to fund ongoing research and clinical development of product candidates, as well as for working capital and general corporate purposes.
Analysis · VANI · Industrial Applications And Services
This filing details a crucial capital raise for Vivani Medical, a clinical-stage biopharmaceutical company. The ability to secure $4.5 million in gross proceeds, representing a substantial portion of its market capitalization, is vital for funding ongoing research and clinical development. The pricing of the shares at $1.48, which is above the current market price of $1.38, is a particularly strong positive signal, suggesting institutional confidence in the company's valuation. Furthermore, the significant $2.0 million investment by Chairman Gregg Williams in the concurrent private placement, building on his recent Form 4 purchase on January 20, 2026, underscores a robust vote of confidence from a key insider. This capital infusion provides essential runway for the company's operations and product pipeline advancement.
How filings like this one have moved
In the 30 days to Sep 19, 2026, 39.3% of the 351 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, VANI was trading at $1.38 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $100.7M. The 52-week trading range was $0.91 to $1.92. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.